StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note published on Friday. The firm issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Up 7.8 %
RKDA opened at $5.00 on Friday. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The business has a 50 day moving average price of $4.70 and a two-hundred day moving average price of $3.61. The company has a market cap of $6.83 million, a PE ratio of -1.17 and a beta of 0.90.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- Golden Cross Stocks: Pattern, Examples and Charts
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Market Cap Calculator: How to Calculate Market Cap
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is the MACD Indicator and How to Use it in Your Trading
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.